Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 3 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 3

From: Role of fused PET/CT compared to the standard contrast-enhanced CT in the follow-up assessment of the treated gastric malignancy

Fig. 3

Axial post-contrast CT, PET, and fused PET-CT images for a 69-year-old male patient with gastric carcinoma and had received chemotherapy. Images a–c showed FDG avid metabolically active irregular circumferential gastric mural lesions (yellow arrows) reaching 3.2 cm along the gastric fundus and body with SUVmax ~ 19.3, in addition to multiple hypermetabolic gastrohepatic and porta hepatis lymph nodes (red arrows); the largest measures 3.5 cm with SUVmax ~ 8.9. Images d–f showed few FDG avid metabolically active hypodense hepatic dome focal lesions (yellow arrows), the largest and the most active one measures 1.4 cm with SUVmax ~ 6.1

Back to article page